173 related articles for article (PubMed ID: 20124257)
1. Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase.
Plihtari R; Hurt-Camejo E; Oörni K; Kovanen PT
J Lipid Res; 2010 Jul; 51(7):1801-9. PubMed ID: 20124257
[TBL] [Abstract][Full Text] [Related]
2. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans.
Oörni K; Hakala JK; Annila A; Ala-Korpela M; Kovanen PT
J Biol Chem; 1998 Oct; 273(44):29127-34. PubMed ID: 9786921
[TBL] [Abstract][Full Text] [Related]
3. Lipolysis of LDL by human secretory phospholipase A(2) induces particle fusion and enhances the retention of LDL to human aortic proteoglycans.
Hakala JK; Oörni K; Pentikäinen MO; Hurt-Camejo E; Kovanen PT
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1053-8. PubMed ID: 11397719
[TBL] [Abstract][Full Text] [Related]
4. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules.
Paananen K; Kovanen PT
J Biol Chem; 1994 Jan; 269(3):2023-31. PubMed ID: 8294453
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans.
Oörni K; Posio P; Ala-Korpela M; Jauhiainen M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1678-83. PubMed ID: 15879301
[TBL] [Abstract][Full Text] [Related]
6. Acidity and lipolysis by group V secreted phospholipase A(2) strongly increase the binding of apoB-100-containing lipoproteins to human aortic proteoglycans.
Lähdesmäki K; Öörni K; Alanne-Kinnunen M; Jauhiainen M; Hurt-Camejo E; Kovanen PT
Biochim Biophys Acta; 2012 Feb; 1821(2):257-67. PubMed ID: 22041135
[TBL] [Abstract][Full Text] [Related]
7. Differences between group X and group V secretory phospholipase A(2) in lipolytic modification of lipoproteins.
Kamitani S; Yamada K; Yamamoto S; Ishimoto Y; Ono T; Saiga A; Hanasaki K
Cell Mol Biol Lett; 2012 Sep; 17(3):459-78. PubMed ID: 22706677
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase A(2)-modified LDL particles retain the generated hydrolytic products and are more atherogenic at acidic pH.
Lähdesmäki K; Plihtari R; Soininen P; Hurt-Camejo E; Ala-Korpela M; Oörni K; Kovanen PT
Atherosclerosis; 2009 Dec; 207(2):352-9. PubMed ID: 19473659
[TBL] [Abstract][Full Text] [Related]
9. Hydrolysis of lipoproteins by sPLA2's enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2's IIA, V and X.
Pruzanski W; Kopilov J; Kuksis A
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():64-8. PubMed ID: 26711221
[TBL] [Abstract][Full Text] [Related]
10. Decrease in pH strongly enhances binding of native, proteolyzed, lipolyzed, and oxidized low density lipoprotein particles to human aortic proteoglycans.
Sneck M; Kovanen PT; Oörni K
J Biol Chem; 2005 Nov; 280(45):37449-54. PubMed ID: 16147996
[TBL] [Abstract][Full Text] [Related]
11. Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin.
Hakala JK; Oörni K; Ala-Korpela M; Kovanen PT
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1276-83. PubMed ID: 10323780
[TBL] [Abstract][Full Text] [Related]
12. Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans.
Boyanovsky BB; van der Westhuyzen DR; Webb NR
J Biol Chem; 2005 Sep; 280(38):32746-52. PubMed ID: 16040605
[TBL] [Abstract][Full Text] [Related]
13. Proteolysis and fusion of low density lipoprotein particles strengthen their binding to human aortic proteoglycans.
Paananen K; Saarinen J; Annila A; Kovanen PT
J Biol Chem; 1995 May; 270(20):12257-62. PubMed ID: 7744877
[TBL] [Abstract][Full Text] [Related]
14. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.
Wooton-Kee CR; Boyanovsky BB; Nasser MS; de Villiers WJ; Webb NR
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):762-7. PubMed ID: 14962950
[TBL] [Abstract][Full Text] [Related]
15. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
Hanasaki K; Yamada K; Yamamoto S; Ishimoto Y; Saiga A; Ono T; Ikeda M; Notoya M; Kamitani S; Arita H
J Biol Chem; 2002 Aug; 277(32):29116-24. PubMed ID: 12021277
[TBL] [Abstract][Full Text] [Related]
16. Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro.
Oörni K; Sneck M; Brömme D; Pentikäinen MO; Lindstedt KA; Mäyränpää M; Aitio H; Kovanen PT
J Biol Chem; 2004 Aug; 279(33):34776-84. PubMed ID: 15184381
[TBL] [Abstract][Full Text] [Related]
17. Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2.
Pruzanski W; Lambeau L; Lazdunsky M; Cho W; Kopilov J; Kuksis A
Biochim Biophys Acta; 2005 Sep; 1736(1):38-50. PubMed ID: 16122976
[TBL] [Abstract][Full Text] [Related]
18. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation.
Nguyen SD; Javanainen M; Rissanen S; Zhao H; Huusko J; Kivelä AM; Ylä-Herttuala S; Navab M; Fogelman AM; Vattulainen I; Kovanen PT; Öörni K
J Lipid Res; 2015 Jun; 56(6):1206-21. PubMed ID: 25861792
[TBL] [Abstract][Full Text] [Related]
20. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet.
Rosengren B; Peilot H; Umaerus M; Jönsson-Rylander AC; Mattsson-Hultén L; Hallberg C; Cronet P; Rodriguez-Lee M; Hurt-Camejo E
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1579-85. PubMed ID: 16601231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
